
Sign up to save your podcasts
Or


Send us a text
In this episode of Life Science Success, I interviewed Mark Gordon. Mark is the CEO of Diviner, a company that has developed a novel collective intelligence technique to help investors and biopharma make better drug development decisions. This company is at the intersection of data/analytics and biopharma.
By Don Davis PhD, MBA5
1010 ratings
Send us a text
In this episode of Life Science Success, I interviewed Mark Gordon. Mark is the CEO of Diviner, a company that has developed a novel collective intelligence technique to help investors and biopharma make better drug development decisions. This company is at the intersection of data/analytics and biopharma.

763 Listeners

820 Listeners

6,266 Listeners

29,313 Listeners

20 Listeners

20,847 Listeners

1,379 Listeners